StonvexLoading…
StonvexStonvexStonvexCore line items from CVGW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $648.43M | $661.54M | $594.10M | $769.69M |
Operating Income | $19.61M | $16.72M | $12.21M | $6.79M |
Net Income | $19.80M | $-1.08M | $-8.34M | $-6.25M |
EPS (Diluted) | $1.11 | $-0.06 | $-0.47 | $-0.35 |
Total Assets | $292.25M | $301.12M | $386.85M | $385.75M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $61.16M | $57.03M | $2.09M | $2.06M |
Free Cash Flow OCF − CapEx | $19.39M | $21.53M | $-25.16M | $40.46M |
Shares Outstanding | 17.86M | 17.80M | 17.76M | 17.73M |